期刊语言：英语

出版地区：瑞士

万维提示

1、投稿方式：在线投稿。

2、期刊网址：

https://www.karger.com/Journal/Home/223996

3、投稿网址：

https://www.manuscriptmanager.net/DSU?product_id=223996

4、官网邮箱：dsu@karger.com

5、官网电话：+41 61 306 1517

6、期刊刊期：双月刊，逢单月出版。

2021年5月29日星期六

投稿须知【官网信息】

Digestive Surgery

Author Guidelines

About the Journal

Aims and Scope

Digestive Surgery presents a comprehensive overview in the field of gastrointestinal surgery. Interdisciplinary in scope, the journal keeps the specialist aware of advances in all fields that contribute to improvements in the diagnosis and treatment of gastrointestinal disease. Particular emphasis is given to articles that evaluate not only recent clinical developments, especially clinical trials and technical innovations such as new endoscopic and laparoscopic procedures, but also relevant translational research. Each contribution is carefully aligned with the need of the digestive surgeon. Thus, the journal is an important component of the continuing medical education of surgeons who want their practice to benefit from a familiarity with new knowledge in all its dimensions.

Journal Sections

Historical Reviews

How I Do It

Method articles which describe modern operative techniques in the field of gastrointestinal surgery. The manuscript should be short and precise and should contain 1–4 high-quality videos to explain the surgical procedure. Decisions of submitted papers within 6 weeks: A decision will be reached within 6 weeks for manuscripts submitted to the 'How I do it' section.

Article Types

Research Article

Research Articles report on primary research. They must describe significant and original observations. Consideration for publication is based on the article’s originality, novelty, and scientific soundness, and the appropriateness of its analysis.

Research Articles are reports of original work. Authors are asked to follow the EQUATOR Network for Research Articles.

Prior approval from an Institutional Review Board (IRB) or an Ethics Review Committee is required for all investigations involving human subjects.

A downloadable template is available below.

Documents

Research Article (DOCX, 28.97 KB)

Research Articles should contain a 200-word abstract, 2'000-word body text, 25 references, and 2-4 figures and/or tables.

Review Article

Review Articles are considered reviews of research or summary articles. They are state-of-the-art papers covering a current topic by experts in the field. They should give evidence on and provide answers to a well-defined aspect or question in a particular area. Review Articles must include a critical discussion of the reported data and give a clear conclusion with potential impacts on the standard of care.

A downloadable template is available below.

Documents

Review Article (DOCX, 23.66 KB)

Review Articles should contain a 200-word abstract, 4'000-word body text, 50 references, and 1-2 figures and/or tables.

Editorial

Editorials provide a viewpoint on specific articles or on general subjects directly relevant to the journal. Editorials are written by an editor or other member of the journal.

Editorials should not exceed 500 words

A downloadable template is available below.

Editorials should contain up to 1000 words and 10 references.

Letter

Letters may explore subjects related to matters discussed in the journal, providing the author’s perspective on a subject. Letters may discuss a recently published article and may lend support or constructively critique the article in line with the author’s experience. The editors reserve the right to share such letters to the authors of the article concerned prior to publication in order to permit response, ideally in the same issue of the journal. Letters should not include original data.

Letters should not exceed 2000 words and have a maximum 15 references & 1 figure/table

A downloadable template is available below.

Documents

Letter (DOCX, 24.24 KB)

Letters should contain no abstract, a 700-word body text, and approx. 5 references.

Methods Article

Methods Articles primarily describe methods or procedures used to perform an experiment or research rather than report the results of the research.

A downloadable template is available below.

Documents

Method Article (DOCX, 24.33 KB)

Methods Articles should contain a 200-word abstract, 2'000-word body text, 25 references, and 2-4 figures and/or tables.

Contact Information

Should you have any problems with your submission, please contact the editorial office:

Marta Raposo Barrero

Editorial Office 'Digestive Surgery'

S. Karger AG

P.O. Box

CH-4009 Basel (Switzerland)

Tel. +41 61 306 1517

Fax +41 61 306 1434

dsu@karger.com

Editorial and Journal Policies

General Conditions

Only papers written in English are considered. The articles should be comprehensible to a reader who is fluent in English and should be edited prior to submission to ensure that standard English grammar and usage are observed. Use of a professional language editing service prior to submission can help avoid delays with the review process.

All manuscripts are subject to editorial review.

The presentation of manuscripts should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals from the International Committee of Medical Journal Editors (ICMJE).

Karger journals aim to adhere to the COPE Code of Conduct and Best Practice Guidelines.

By submitting an article for publication, the authors agree to the transfer of the copyright to the publisher upon acceptance. Accepted papers become the permanent property of the Journal and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

The Submission Statement with original (hand-written) signatures is to be provided upon submitting the paper. If it is not possible to collect all signatures on a single document, individual copies should be provided for each author.

Karger recommends the use of original images and materials whenever possible. If a submitted manuscript contains third-party copyright material(s), it is the authors’ sole responsibility to obtain permission from the relevant copyright holder for reusing the material(s), including any associated licensing fee. The copyright and usage information needs to be checked carefully to avoid copyright infringement.

Most publishers offer a quick and easy way to clear permissions for their content via the built-in website application RightsLink or via https://www.copyright.com/get-permissions/. Another widely used licensing tool is PLSClear. Please check the publishers’ websites for the available options and user instructions.

Statements

All submitted manuscripts must contain a Statement of Ethics, a Conflict of Interest Statement, an Author Contributions Statement and a Data Availability Statement after the main body of the text, but before the reference list.

Statement of Ethics

Published research must comply with internationally-accepted standards for research practice and reporting. Manuscripts may be rejected if the editors believe that the research has not been carried out within an appropriate ethical framework, and concerns raised after publication may lead to a correction, retraction, or expression of concern in line with COPE guidelines.

Studies involving human subjects (including research on identifiable human material and data) must have been performed with the approval of an appropriate ethics committee and with appropriate participants’ informed consent in compliance with the Helsinki Declaration.

In the manuscript, authors should specify the name of the ethics committee or other relevant authority who approved the study protocol and provide the reference number where appropriate. If ethics approval was not required, or if the study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee who made that decision).

For all research involving human subjects, written informed consent to participate in the study should be obtained from participants (or their parent/legal guardian  where appropriate  ) and a statement detailing this should appear in the manuscript. For studies involving vulnerable participants or participants at risk of potential coercion, detailed information regarding the steps taken to ensure informed consent must be provided. If consent was not obtained, please specify why and whether this was approved by the ethics committee.

In line with the ICMJE recommendations on the protection of research participants, authors must avoid providing identifying information unless strictly necessary for the submission and participants’ identifiable attributes must be anonymized in the manuscript and its supplementary files, if any. If identifying information is necessary, authors must confirm that the individual has provided written consent for the use of that information in a publication.

Research involving human embryonic stem cells, embryonic germ cells or induced pluripotent stem cells should comply with the ISSCR 'Guidelines for the Conduct of Human Embryonic Stem Cell Research' or an equivalent set of guidelines or applicable regulations.

Case Reports: Manuscripts reporting a case report must include a statement detailing that written informed consent for publication was obtained and from whom (e.g. “Written informed consent was obtained from the patient for publication of this case report and any accompanying images.”). If the patient has died, consent for publication must be obtained from their next of kin. If the patient described in the case report is a minor or vulnerable, then consent for publication must be obtained from the parent/legal guardian. The completed consent form must be made available to the Editor if requested, and will be treated confidentially.

Clinical Trials:  In accordance with the ICMJE recommendations, all clinical trials should be registered in a publicly available registry approved by the WHO or ICMJE (see the list here) and the clinical trial number must be clearly stated in the manuscript. Manuscripts reporting clinical trials must adhere to the relevant reporting guidelines for their study design, such as CONSORT for randomized controlled trials, TREND for non-randomized trials, or other relevant reporting guidelines as detailed on the Equator network website.

Karger follows the WHO definition of clinical trials "A clinical trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes [...] Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes, preventive care, etc. This definition includes Phase I to Phase IV trials.”

……

更多详情：

https://www.karger.com/Journal/Guidelines/223996